• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

Comprehensive Overview of 3-methyl-4-(pyridin-3-yloxy)aniline (CAS No. 383434-56-8): Properties, Applications, and Industry Insights

3-methyl-4-(pyridin-3-yloxy)aniline (CAS No. 383434-56-8) is a specialized organic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. This aniline derivative combines a pyridine ring and a methyl-substituted aromatic amine, making it a versatile intermediate for synthesizing biologically active molecules. Its molecular formula C₁₂H₁₂N₂O and molecular weight of 200.24 g/mol position it as a critical building block in modern drug discovery pipelines.

The compound's pyridinyloxy-aniline scaffold is particularly noteworthy for its ability to modulate enzyme interactions, a property exploited in designing kinase inhibitors and antimicrobial agents. Recent studies highlight its potential in addressing antibiotic resistance—a top-priority global health challenge—by serving as a precursor for novel broad-spectrum antibacterial compounds. Researchers are actively investigating its role in developing next-generation crop protection agents, aligning with the growing demand for sustainable agriculture solutions.

From a synthetic chemistry perspective, 3-methyl-4-(pyridin-3-yloxy)aniline demonstrates remarkable stability under various reaction conditions. Its electron-rich aromatic system facilitates diverse functionalization reactions, including palladium-catalyzed cross-couplings and electrophilic substitutions. This adaptability makes it invaluable for creating structure-activity relationship (SAR) libraries during lead optimization phases. The compound's logP value of 2.1 suggests favorable membrane permeability, a key consideration in drug-likeness assessments.

Analytical characterization of CAS No. 383434-56-8 typically involves advanced techniques such as HPLC-MS purity analysis and multinuclear NMR spectroscopy. The compound exhibits characteristic ¹H NMR signals at δ 7.8-6.5 ppm (aromatic protons) and δ 2.2 ppm (methyl group), with mass spectral fragmentation patterns confirming its structural integrity. These analytical signatures are crucial for quality control in GMP-compliant manufacturing processes.

In material science applications, the 3-methyl-4-(pyridin-3-yloxy)aniline framework has shown promise in developing organic semiconductors and photocatalytic systems. Its conjugated π-system and nitrogen heteroatoms enable charge transport properties relevant to optoelectronic devices, meeting industry demands for renewable energy technologies. Computational studies predict strong adsorption on metal oxide surfaces, suggesting applications in sensor technology for environmental monitoring.

The global market for fine chemical intermediates like CAS No. 383434-56-8 is projected to grow at 6.8% CAGR through 2030, driven by expanding biopharmaceutical R&D investments. Regulatory considerations emphasize proper handling under standard laboratory protocols, with SDS documentation detailing appropriate storage conditions (typically 2-8°C under inert atmosphere). As synthetic methodologies advance, particularly in continuous flow chemistry, production scalability of such specialized intermediates continues to improve.

Emerging research explores the compound's potential in targeted protein degradation (PROTAC technology) and fluorescent probe development for bioimaging. These cutting-edge applications leverage its balanced hydrophilicity/lipophilicity and ability to form stable molecular complexes. With increasing focus on precision medicine and theranostic agents, 3-methyl-4-(pyridin-3-yloxy)aniline derivatives may play pivotal roles in future diagnostic and therapeutic innovations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)